Article info
PDFCorrespondence
Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’
- Correspondence to Dr Haiyan Yang, Department of Epidemiology, Zhengzhou University, Zhengzhou 450001, China; yhy{at}zzu.edu.cn; Dr Yadong Wang, Department of Toxicology, Henan Center for Disease Control and Prevention, Zhengzhou 450016, China; wangyd76{at}163.com
Citation
Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’
Publication history
- Received December 30, 2020
- Accepted January 2, 2021
- First published January 15, 2021.
Online issue publication
October 18, 2023
Article Versions
- Previous version (18 October 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage